Comparison of efficacy and safety of Vildagliptin and Teneligliptin in patients with Type 2 Diabetes Mellitus
Not Applicable
- Conditions
- Health Condition 1: null- Type 2 Diabetes Mellitus
- Registration Number
- CTRI/2017/02/007766
- Lead Sponsor
- jawaharlal nehru medical college and hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Open to Recruitment
- Sex
- Not specified
- Target Recruitment
- 160
Inclusion Criteria
Newly diagnosed type 2 Diabetes mellitus
poorly controlled diabetics on oral hypoglycemic agents
Exclusion Criteria
Type 1 DM
Patients on insulin
Diabetic Ketoacidosis
Diabetic Nephropathy
CHF
Septicaemia
Psychotic Patients
Pregnancy
Known case of HIV/HBs Ag/HCV and immunocompromised patients
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Glycated Haemoglobin <br/ ><br>Timepoint: 0,12.24 weeks <br/ ><br>
- Secondary Outcome Measures
Name Time Method Fasting and Post prandial plasma GlucoseTimepoint: 0,6,12,18,24 weeks